Cheryl Ho, MD, Howard J. Lim, MD, Dean A. Regier, PhD

Canadian Regulatory and Health Technology Assessment for Malignant Hematology and Oncology Indications Compared With the US Food and Drug Administration Accelerated Approval Program

Jun 5^th • 6 mins read